Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Gel vs Spray for Pediatric Allergic Rhinitis
NCT02953366Phase 3Withdrawn
- Sponsor
- EMS
- Start
- May 2019
- Primary completion
- Dec 2019
- Modality
- Nanoparticles, Small Molecules
01
Overview
A Phase 3 trial of Mometasone furoate nano-nasal spray in allergic rhinitis (AR), sponsored by EMS. Planned start May 2019; status: withdrawn.
02
Drugs
Mometasone furoate nano-nasal spray
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02953366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953366.